{
  "pmcid": "4033571",
  "config": {
    "model": "gemini",
    "strategy": "few-shot"
  },
  "usage": {
    "input": 18363,
    "output": 923
  },
  "raw_text": "Based on the provided article, here are the extracted arm-level statistics for the specified ICO triplets.\n\n```json\n{\n  \"extractions\": [\n    {\n      \"outcome\": \"Overall seizure median percent improvement\",\n      \"intervention\": \"Extended-release oxcarbazepine 2400 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 111,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 117,\n      \"intervention_mean\": -42.9,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": -28.7,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Adverse effects\",\n      \"intervention\": \"Extended-release oxcarbazepine 1200 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 69,\n      \"intervention_group_size\": 122,\n      \"comparator_events\": 67,\n      \"comparator_group_size\": 121,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Overall seizure median percent reduction\",\n      \"intervention\": \"Extended-release oxcarbazepine 1200 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 109,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 117,\n      \"intervention_mean\": -38.2,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": -28.7,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Seizure median percent improvement in North America\",\n      \"intervention\": \"Extended-release oxcarbazepine 1200 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 40,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 41,\n      \"intervention_mean\": -34.5,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": 13.3,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Seizure median percent improvement in North America\",\n      \"intervention\": \"Extended-release oxcarbazepine 2400 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 35,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 41,\n      \"intervention_mean\": -52.7,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": 13.3,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"Adverse effects\",\n      \"intervention\": \"Extended-release oxcarbazepine 2400 mg\",\n      \"comparator\": \"Control\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 85,\n      \"intervention_group_size\": 123,\n      \"comparator_events\": 67,\n      \"comparator_group_size\": 121,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    }\n  ]\n}\n```",
  "extraction": [
    {
      "outcome": "Overall seizure median percent improvement",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 111,
      "comparator_events": null,
      "comparator_group_size": 117,
      "intervention_mean": -42.9,
      "intervention_standard_deviation": null,
      "comparator_mean": -28.7,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Adverse effects",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "binary",
      "intervention_events": 69,
      "intervention_group_size": 122,
      "comparator_events": 67,
      "comparator_group_size": 121,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Overall seizure median percent reduction",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 109,
      "comparator_events": null,
      "comparator_group_size": 117,
      "intervention_mean": -38.2,
      "intervention_standard_deviation": null,
      "comparator_mean": -28.7,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Seizure median percent improvement in North America",
      "intervention": "Extended-release oxcarbazepine 1200 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 40,
      "comparator_events": null,
      "comparator_group_size": 41,
      "intervention_mean": -34.5,
      "intervention_standard_deviation": null,
      "comparator_mean": 13.3,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Seizure median percent improvement in North America",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 35,
      "comparator_events": null,
      "comparator_group_size": 41,
      "intervention_mean": -52.7,
      "intervention_standard_deviation": null,
      "comparator_mean": 13.3,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    },
    {
      "outcome": "Adverse effects",
      "intervention": "Extended-release oxcarbazepine 2400 mg",
      "comparator": "Control",
      "outcome_type": "binary",
      "intervention_events": 85,
      "intervention_group_size": 123,
      "comparator_events": 67,
      "comparator_group_size": 121,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4033571"
    }
  ]
}